On September 25, 2026 Menlo Park-based ProDx announced a partnership with Kink.com to run on-site STI testing from the Kink Center store in San Francisco across the Folsom Street Festival weekend — Friday evening through Sunday. Per the announcement, ProDx staffed a Pro13 booth for on-site testing, kit pick-up and kit drop-off, with turnaround engineered around the event schedule: kits dropped off Friday and Saturday returned results the following day, and kits handed in Sunday between 10am and 1pm returned results before Kink.com's 6pm party.

Why It Matters

Sexual-health testing has spent a decade solving for convenience — mail a kit, prick a finger, wait a week — and in doing so has systematically ignored the population with the highest testing need and the lowest follow-through. Meeting people at a kink event with a phlebotomist and a same-day result is a distribution strategy, not a marketing stunt: it puts the test where the intent is, removes the return-shipping step entirely, and closes the loop before the weekend ends. That is the STI-testing equivalent of a pop-up vaccination clinic, and the reason public health keeps running those. There's a commercial read too. Kink.com is providing something a diagnostics startup cannot buy — trusted access to a community that has good historical reasons to be wary of clinical settings. In exchange, Kink gets to attach a harm-reduction service to its own event programming. That trade — platform or venue supplies the audience and the trust, diagnostics company supplies the clinical capability — is the same structure behind Everlywell's payer partnerships and Teal Health's telehealth wrap, just executed at street level instead of through a health plan. Expect more of it: as at-home testing commoditises, the differentiator stops being the assay and becomes the channel. Whoever owns access to the people most likely to need a test owns the category.

The operational detail that matters is the last one. Same-day turnaround at a public event is a materially different product from at-home mail-in testing, which is what most of this category ships. "We're excited to be part of this event, and so thankful Kink.com made this possible," said ProDx founder Dr. K. "Stop by our booth and get tested — if you need help, we can help you, or we can do the draw for you." Performing the blood draw at the booth, rather than handing over a self-collection kit and hoping it comes back, closes the single biggest leak in at-home testing: the kit that never gets returned.

ProDx is not new to this beat. The company's Pro13 Home Collect STI Panel earned four nominations at the 2026 Stimulate Awards in Nashville, judged by a clinical, therapy and education panel — one of the clearer signals that at-home sexual-health diagnostics has been absorbed into the sexual-wellness industry proper rather than sitting adjacent to it.

Sources

Update — 2026-09-27

Initial entry — story first created.